Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Core Laboratories 14-Day RSI Related Terms
CLB vs EROK, OIS, NGS: 14-Day RSI Comparison
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories 14-Day RSI vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Core Laboratories's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories (CLB) has a 14-Day RSI of 48.86 as of Aug. 05, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Core Laboratories and its competitors. According to the industry distribution chart, Core Laboratories ranks #492 out of 1056 companies in the Oil & Gas industry, placing it in the top 46.6%.
Is Core Laboratories' 14-Day RSI too high?
Core Laboratories' current 14-Day RSI is 48.86. The Oil & Gas industry median 14-Day RSI is 49.53. Core Laboratories' value of 48.86 is 1.4% below this industry median. Based on the distribution chart, Core Laboratories ranks #492 out of 1056 companies in the Oil & Gas industry, which is above the industry midpoint. Overall, Core Laboratories has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' 14-Day RSI compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #492 out of 1056 companies for 14-Day RSI. This puts Core Laboratories in the upper half of its industry. The industry median 14-Day RSI is 49.53. Core Laboratories' value of 48.86 is 1.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for an Oil & Gas company?
The median 14-Day RSI among Oil & Gas companies is 49.53, based on 1,056 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current 14-Day RSI of 48.86 is 1.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median 14-Day RSI is 49.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current 14-Day RSI is 48.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Core Laboratories (CLB) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.18, compared to a current price of $10.95 — trading 36.3% below its estimated fair value. The current 14-Day RSI is 48.86 and 1.4% below the Oil & Gas industry median of 49.53. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Core Laboratories (CLB), the current 14-Day RSI is 48.86 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of $10.95 is trading 36.3% below its estimated GF Value™ of $17.18.
GuruFocus considers Core Laboratories to be Significantly Undervalued.
Key valuation signals for CLB:
14-Day RSI: 48.86
GF Value™: $17.18 vs. price of $10.95 (36.3% below fair value)
Industry Position: 1.4% below the Oil & Gas median (#492 of 1056)
No single metric tells the full story. See the CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for CLB
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLB has been successfully added to your 
